|
| Press Releases |
|
 |
|
| Monday, March 14, 2022 |
|
|
雅各臣獲主席增持股份至超過六成 |
| 從事基礎藥物、專科藥物及品牌醫療保健產品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司（「公司」；連同其附屬公司統稱「集團」；股份代號：2633 ) 獲集團主席岑廣業先生於二零二一年十二月十五日至二零二二年三月十四日期間 more info >> |
|
|
Jacobson Pharma's Chairman Uplifts Shareholding to Above 60% |
| Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma Corporation Limited (the "Company"; together with its subsidiaries, the "Group"; Stock Code: 2633), a leading company engaged in the research more info >> |
|
| Friday, November 26, 2021 |
|
|
雅各臣公布二零二二财年中期业绩 |
| 从事基础药物、专科药物及品牌医疗保健产品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「公司」；股份代号：2633 )今天公布公司及其附属公司（统称「集团」）截至二零二一年九月三十日止六个月（「报告期」）的中期业绩。 more info >> |
|
|
雅各臣公佈二零二二財年中期業績 |
| 從事基礎藥物、專科藥物及品牌醫療保健產品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司（「雅各臣」或「公司」；股份代號：2633 )今天公佈公司及其附屬公司（統稱「集團」）截至二零二一年九月三十日止六個月（「報告期」）的中期業績。 more info >> |
|
|
Jacobson Pharma Announces FY2022 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines more info >> |
|
| Tuesday, June 29, 2021 |
|
|
雅各臣公布二零二一财年全年业绩 |
| 从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「公司」；股份代号：2633 )今天公布公司及其附属公司（统称「集团」）于截至二零二一年三月三十一日止年度（「二零二一财年」或「报告期」）的全年业绩。 more info >> |
|
|
雅各臣公佈二零二一財年全年業績 |
| 從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司（「雅各臣」或「公司」；股份代號：2633 )今天公佈公司及其附屬公司（統稱「集團」）於截至二零二一年三月三十一日止年度（「二零二一財年」或「報告期」）的全年業績。 more info >> |
|
|
Jacobson Pharma Announces FY2021 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products more info >> |
|
| Friday, February 5, 2021 |
|
|
健倍苗苗（保健）有限公司於香港聯交所主板掛牌上市 |
| 健倍苗苗（保健）有限公司 （「健倍苗苗」 或「公司」，連同其附屬公司統稱「集團」），一家總部設於香港的領先品牌醫療保健品推廣及分銷公司，業務遍及大中華、東南亞及其他選定國家，今天於香港聯合交易所有限公司（「香港聯交所」）主板正式掛牌買賣，股份代號為2161。 more info >> |
|
|
JBM (Healthcare) Limited Debuts on The Main Board of SEHK |
| JBM (Healthcare) Limited ("JBM Healthcare" or "Company", together with its subsidiaries, the "Group"), a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia and certain other countries, started trading today on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") under stock code 2161. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Launch of World-first Expert Bone Health Resource
May 23, 2022 15:48: JST
|
|
|
マツダ、「フレアクロスオーバー」を一部商品改良
May 23, 2022 15:00: JST
|
|
|
Launch of World-first Expert Bone Health Resource
May 23, 2022 14:48 HKT/SGT
|
|
|
Motul powers Mercedes-AMG Team Craft-Bamboo Racing to iconic P2 finish at Bathurst 12 Hour
May 23, 2022 12:00 HKT/SGT
|
|
|
中国万天控股（01854.HK）立足大湾区 锐意打造大湾区绿色龙头品牌
May 23, 2022 11:46 HKT/SGT
|
|
|
中國萬天控股（01854.HK）立足大灣區 銳意打造大灣區綠色龍頭品牌
May 23, 2022 11:45 HKT/SGT
|
|
|
昭和電工、次世代グリーンパワー半導体用8インチSiCウェハー開発計画がNEDOグリーンイノベーション基金事業に採択
May 23, 2022 11:30: JST
|
|
|
The Wuling COVID Testing Cars will be delivered at the end of May
May 23, 2022 10:53 HKT/SGT
|
|
|
Project-Finance Agreement Signed for MC-Hokuden Hydro Power Alliance
May 23, 2022 11:15 JST
|
|
|
NECプラットフォームズ、エッジAIを用いて自動で排泄検知・通知する介護施設向けシステムを販売
May 23, 2022 10:00: JST
|
|
|
Mitsubishi Motors to Launch the All-New eK X EV in Japan
May 23, 2022 9:36 JST
|
|
|
NEC and Toyota Technical Development Develop Stable Wireless Control System for Cars and other Moving Objects in Factories
May 23, 2022 9:24 JST
|
|
|
nybl Joins World AI Show & Awards as The Official Artificial Intelligence Partner
May 22, 2022 09:07 HKT/SGT
|
|
|
云康集团 (02325.HK) 冀为中国医疗系统创新发展
May 21, 2022 16:11 HKT/SGT
|
|
|
雲康集團 (02325.HK) 冀為中國醫療系統創新發展
May 21, 2022 16:10 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
